Tower Research Capital LLC (Trc) Evotec Se Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.07 - $7.87 $443 - $857	109 New	109 $0
Q4 2022 Feb 10, 2023	SELL	$7.8 - $9.85 $8,853 - $11,179	-1,135 Reduced 98.52%	17 $0
Q3 2022 Nov 10, 2022	BUY	$8.4 - $28.4 $9,676 - $32,716	1,152 New	1,152 $10,000
Q1 2022 May 12, 2022	SELL	$12.93 - $23.46 $1,680 - $3,049	-130 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$22.0 - $25.77 $2,860 - $3,350	130 New	130 $3,000

3.42M

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.68B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.